文献速递胃肠动力与功能性疾病消化内镜

共聚焦激光显微内镜诊断肠易激综合征小麦敏感的 前瞻性双盲多中心研究

Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.
PubMed 文献 · Gut · 2021-09-20

该前瞻性双盲多中心研究纳入147例符合Rome III标准的非乳糜泻IBS患者,以2个月无麸质饮食(GFD)应答作为小麦敏感(WS)参考标准,评估共聚焦激光显微内镜(CLE)的诊断准确性。130例完成研究,74例(56.9%)对GFD应答被归为WS;CLE识别WS的敏感性为51.4%(97.5%CI 38.7%-63.9%),特异性为67.9%(97.5%CI 52.9%-79.9%)。结论认为CLE诊断准确性过低,不推荐广泛使用该侵入性检查。

要点

  • CLE诊断小麦敏感敏感性51.4%、特异性67.9%,准确性不足。
  • 56.9%的IBS患者对2个月无麸质饮食应答,提示小麦敏感比例较高。
  • 6个月随访时CLE敏感性升至83.1%但特异性仅32%。

核心结论

  • 鉴于对GFD应答的IBS患者比例高,CLE诊断准确性过低,不推荐广泛使用该侵入性检查。

研究设计与样本

  • 前瞻性、双盲诊断性多中心研究,纳入147例符合Rome III标准且非乳糜泻的IBS患者。
  • 以2个月GFD应答(采用监管机构推荐的IBS药物试验应答标准)作为WS参考标准。
  • CLE检测十二指肠在暴露于小麦(指标试验)、大豆、酵母或牛奶后的变化。

主要发现

  • 130例完成研究,74例(56.9%)对GFD应答并归为WS。
  • CLE正确识别38/74例WS患者,敏感性51.4%(97.5%CI 38.7%-63.9%)。
  • CLE正确识别38/56例非WS患者,特异性67.9%(97.5%CI 52.9%-79.9%)。
  • 6个月随访时CLE识别59例食物敏感患者中的49例,敏感性83.1%(97.5%CI 69.9%-91.3%),特异性仅32%(97.5%CI 15.7%-54.3%)。

关键数值与推荐

  • 2个月GFD应答采用监管机构推荐的IBS药物试验应答标准作为WS分类依据。
  • 主要结局为CLE识别WS的敏感性和特异性。

临床怎么用

  • 不推荐将CLE作为IBS患者小麦敏感的常规诊断工具。
  • 对GFD应答的IBS患者比例较高,临床需关注小麦敏感可能。

局限性

  • CLE为侵入性检查且诊断准确性不足。
  • 6个月随访时特异性低至32%,远期判别能力有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A considerable proportion of patients with irritable bowel syndrome (IBS) may be wheat-sensitive and respond to a gluten-free diet (GFD) although they do not have coeliac disease. However, a diagnostic test for wheat sensitivity (WS) is missing. Our study evaluated the diagnostic accuracy (sensitivity and specificity) of confocal laser endomicroscopy (CLE) for the identification of WS as primary outcome. DESIGN: In this prospective, double-blind diagnostic study 147 non-coeliac patients fulfilling the Rome III criteria for IBS were tested by CLE for duodenal changes after wheat (index test), soy, yeast or milk exposure. Patients with IBS responding to 2 months of GFD were classified as having WS (reference test) using response criteria recommended by regulatory bodies for pharmaceutical trials of patients with IBS. After 2 months, CLE results were unblinded and patients were advised to exclude those food components that had led to a positive CLE reaction. The clinical response was assessed at follow-up after 6 and 12 months. RESULTS: Of 130 patients who completed the study per protocol, 74 (56.9%) responded to GFD and were classified as WS after 2 months, and 38 of these 74 patients were correctly identified by CLE (sensitivity 51.4%; 97.5% CI: 38.7% to 63.9%). A total of 38 of 56 patients without WS were correctly identified by CLE (specificity 67.9%; 97.5% CI: 52.9% to 79.9%). At 6 months follow-up, CLE correctly identified 49 of 59 food-sensitive patients (sensitivity 83.1%; 97.5% CI: 69.9% to 91.3%) but specificity was only 32% (97.5% CI: 15.7% to 54.3%). CONCLUSION: In light of the high proportion of patients with IBS responding to GFD, the diagnostic accuracy of CLE is too low to recommend widespread use of this invasive procedure. TRAIL REGISTRATION NUMBER: This study was registered as clinical trial in the German Registry for Clinical Studies (DRKS00010123).

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Bojarski C, Tangermann P, Barmeyer C, et al. Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome. Gut. 2021. PMID: 34544843. doi:10.1136/gutjnl-2021-325181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。